Poland· PL-100214548

Uralex

A oxybutynin product containing oxybutynini hydrochloridum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC G04BD04

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxybutynini hydrochloridumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxybutynin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD04 (oxybutynin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search oxybutynin products by name

Oxybutynin · ATC G04BD04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxybutynin costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.17 in France to $2.99 in Switzerland — a ×18 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Oxybutynin · price per daily dose (15 mg)

USD · FX 28 Sept 2026

CH Switzerland$2.99
IT Italy$0.59
US United States$0.20 (acquisition cost)
FR France$0.17

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Oxybutynini hydrochloridum
Manufacturer: Accord Healthcare Polska Sp. z o.o.
Country: Poland (PL)
ATC code: G04BD04
ATC class: Oxybutynin
Defined daily dose: 15 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 10

gtin
05909991035952
gtin
05909991035969
gtin
05909991035976
gtin
05909991035983
gtin
05909991035990
gtin
05909991036003
gtin
05909991036034
gtin
05909991036041
gtin
05909991036058
gtin
05909991036294

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

312 interactions on record for oxybutynin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxybutynin against other medicines How interaction checks work

Oxybutynin · interactions on record

312 records

3 severe
103 moderate
1 minor
168 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium chlorideB05XA01severe
DicycloverineA03AA07moderate

37 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxybutynin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxybutynin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Detrusan, Ditropan
Belgium · Oxybutynine Eg, Velariq
Bulgaria · Дриптан
Czechia · Tarraconiq, Uroxal
Germany · Dridase, Oxybutynin Aaa-Pharma
Denmark · Oxybutynin Macure, Oxybutynin Unimedic
Estonia · Driptane
Spain · Ditropan, Dresplan
Finland · Oxybutynin Macure, Oxybutynin Unimedic
France · Ditropan, Oxybutynine Accord
United Kingdom (Northern Ireland) · Ditropan, Oxybutynin Hydrochloride
Greece · Ditropan
Hungary · Ditropan, Uroxal
Ireland · Oxybutynin Hydrochloride Accord Healthcare Ireland, Oxybutynin Hydrochloride Syri Pharma
Iceland · Kentera
Italy · Ditropan, Ossibutinina Cloridrato Mylan Generics
Liechtenstein · Kentera
Lithuania · Driptane
Luxembourg · Oxybutynine Eg, Velariq
Latvia · Driptane
Netherlands · Dridase, Oxybutinin Hydrochloride Aurobindo
Norway · Kentera, Oxybutynin Macure
Portugal · Ditropan, Velariq
Romania · Driptane
Sweden · Ditropan, Oxybutynin Accord
Slovakia · Uroxal, Velariq

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b7714229-5cc9-4560-aaae-ae0c57fbefa4
GET /v1/drugs/b7714229-5cc9-4560-aaae-ae0c57fbefa4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "5 mg",
  "packaging": "05909991035952 ¦ Rp ¦ 81675\n6 tabl.\n05909991035969 ¦ Rp ¦ 81676\n21 tabl.\n05909991035976 ¦ Rp ¦ 81677\n28 tabl.\n05909991035983 ¦ Rp ¦ 81678\n30 tabl.\n05909991035990 ¦ Rp ¦ 81679\n50 tabl.\n05909991036003 ¦ Rp ¦ 81680\n56 tabl.\n05909991036034 ¦ Rp ¦ 81681\n60 tabl.\n05909991036041 ¦ Rp ¦ 81682\n84 tabl.\n05909991036058 ¦ Rp ¦ 81683\n100 tabl.\n05909991036294 ¦ Rp ¦ 81705\n20 tabl.",
  "substance": "Oxybutynini hydrochloridum 5 mg",
  "common_name": "Oxybutynini hydrochloridum",
  "pl_product_id": "100214548",
  "pozwolenie_nr": "20867",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about oxybutynin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console